Le Lézard
Classified in: Science and technology
Subjects: PDT, ASI

Axcelis Announces Shipment Of The Second 'Purion XEmax' To A Leading Foundry In Asia Pacific


BEVERLY, Mass., Feb. 22, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of innovative, high-productivity solutions for the semiconductor industry, announced today that it has shipped the second Purion XEmaxtm high energy evaluation system to a leading foundry in the Asia Pacific region. The Purion XEmax will be used for CMOS image sensor manufacturing. The system shipped in the first quarter.

Bill Bintz, Executive Vice President, Product Development explained, "We are excited by recent evaluation shipments of new Purion product extensions that will increase our footprint and drive Axcelis toward our $650M target business model. Strong growth in the image sensor market continues to drive robust demand for high energy implant. The new Purion XEmax, combined with the popular Purion XE family of products, will extend Axcelis' market and technology leadership in this high growth market."

The Purion XEmax
The new Purion XEmax high energy implanter was designed for emerging, high performance image sensor applications. The enhanced beamline features multiple filtration systems to eliminate energetic metal contaminants which can otherwise result in compromised dark current and white pixel count levels. The new system is built on the industry leading Purion XE high energy implant platform and features Axcelis' new patented Boost Technologytm, which delivers beam energies up to 15 MeV. With innovative new technology, the Purion XEmax is delivering the most precise angle and overall process control to enable higher quality photodiode performance for next generation CIS devices.

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:
Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

SOURCE Axcelis Technologies, Inc.


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 15:02
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

at 13:12
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 11:49
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...

at 10:00
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week. "With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...



News published on and distributed by: